2. Academic Validation
  3. M1-type microglia-derived exosomes contribute to blood-brain barrier damage

M1-type microglia-derived exosomes contribute to blood-brain barrier damage

  • Brain Res. 2024 Apr 6:1835:148919. doi: 10.1016/j.brainres.2024.148919.
Wen Jiang 1,  Yan Wu 2,  Ailan Pang 2,  Peiyao Li 3,  Song Mei 4
Affiliations

Affiliations

  • 1 Department of Neurology, the First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming 650032, Yunnan, China; The Yunnan Province Clinical Research Center for Neurological Diseases, No.295 Xichang Road, Kunming 650032, Yunnan, China.
  • 2 Department of Neurology, the First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming 650032, Yunnan, China.
  • 3 Department of Pain Medicine, the First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming 650032, Yunnan, China.
  • 4 Department of Cardiac Surgery, the First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming 650032, Yunnan, China. Electronic address: [email protected].
PMID: 38588846 DOI: 10.1016/j.brainres.2024.148919
Abstract

Background: As a key substance for intercellular communication, exosomes could be a potential strategy for stroke treatment. Activated microglia disrupt the integrity of blood-brain barrier (BBB) to facilitate the stroke process. Hence, this study was designed to investigate the effect of microglia-derived exosomes on BBB cell model injury and to explore the underlying molecular mechanisms.

Methods: M1 polarization of BV2 cells was induced with LPS and their derived exosomes were isolated. Astrocytes were cultured in primary culture and constructed with End3 cells as a BBB cell model. After co-culture with exosomes, the BBB cell model was examined for changes in TEER, permeability, and expression of BBB-related proteins (Claudin-1, Occludin, ZO-1 and JAM). Resting and M1-type BV2 cell-derived exosomes perform small RNA sequences and differentially expressed miRNAs (DE-miRNAs) are identified by bioinformatics.

Results: M1-type BV2 cell-derived exosomes decreased End3 cell viability, and increased their apoptotic ratio. Moreover, M1 type BV2 cell-derived exosomes dramatically enhanced the permeability of BBB cell model, and diminished the TEER and BBB-related protein (Claudin-1, Occludin, ZO-1) expression. Notably, resting BV2 cell-derived exosomes had no effect on the integrity of BBB cell model. Sequencing results indicated that 71 DE-miRNAs were present in M1 BV2 cell-derived exosomes, and their targets mediated neurological development and signaling pathways such as MAPK and cAMP. RT-qPCR confirmed the differential expression of mmu-miR-125a-5p, mmu-miR-122b-3p, mmu-miR-139-3p, mmu-miR-330-3p, mmu-miR-3057-5p and mmu-miR-342-3p consistent with the small RNA sequence. Furthermore, Creb1, Jun, mTOR, Frk, Pabpc1 and Sdc1 are the most well-connected proteins in the PPI network.

Conclusion: M1-type microglia-derived exosomes contribute to the injury of BBB cell model, which has the involvement of miRNAs. Our findings provide new perspectives and potential mechanisms for future M1 microglia-derived exosomes as therapeutic targets in stroke.

Keywords

Blood brain barrier; Exosome; MicroRNA; Microglia; Stroke.

Figures
Products